MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Fibromatosis, Abdominal

(UMLS:C0206646)

Definition:: A relatively large mass of unusually firm scarlike connective tissue resulting from active participation of fibroblasts, occurring most frequently in the abdominal muscles of women who have borne children. The fibroblasts infiltrate surrounding muscle and fascia. (Stedman, 25th ed)
UMLS ID:: C0206646
MeSH ID:: D018221

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.450.565.590.340.400

Synonym(s)

Fibromatosis, Abdominal

Abdominal (Mesenteric) Fibromatosis

Abdominal Desmoid

Abdominal Desmoid Tumor

Abdominal Fibromatosis

Abdominal desmoid

Abdominal desmoid tumor

Abdominal fibromatosis

Intraabdominal Desmoid

10.

Intraabdominal Desmoid Tumor

11.

Intraabdominal Fibromatosis

12.

Mesenteric Desmoid

13.

Mesenteric Desmoid Tumor

14.

Mesenteric Fibromatosis

15.

Mesenteric fibromatosis

16.

Retroperitoneal fibromatosis

17.

abdominal desmoid

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Sulindac		14745880	CTD
2	Tamoxifen		14745880	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Fibromatosis, Aggressive	49.6%
2	Fibrosarcoma	34%
3	Myxoma	29.9%
4	Neoplasms, Bone Tissue	29.9%
5	Chondroma	29.9%
6	Enchondroma	29.9%
7	Chondrosarcoma	29.3%
8	synovial sarcoma	29.3%
9	Clear Cell Sarcoma of Soft Tissue	29.3%
10	Dupuytren Contracture	25.9%
11	Malignant Fibrous Histiocytoma	25.7%
12	Sarcoma	25.5%
13	Giant Cell Tumor of Bone	23.7%
14	Dermatofibrosarcoma	21.8%
15	Dermatofibrosarcoma Protuberans	21.8%
16	leukemia	21.3%
17	Neoplasms, Germ Cell and Embryonal	21.3%
18	Neoplasms, Glandular and Epithelial	21.3%
19	Germ Cell Cancer	21.3%
20	Osteosarcoma	21.2%
21	Adenofibroma	20.4%
22	Fibroadenoma	20.4%
23	leiomyosarcoma	18.7%
24	liposarcoma	18.7%
25	Angiomyolipoma	18.7%
26	Alveolar Soft Part Sarcoma	18.7%
27	Osteoblastoma	17.8%
28	Osteoma	17.8%
29	Chondromatosis	17.8%
30	Carcinosarcoma	16.7%
31	Hemangiosarcoma	16.7%
32	lymphangiosarcoma	16.7%
33	Mastocytosis	15.5%
34	Gastrointestinal Stromal Tumors	15.3%
35	Hamartoma	14.8%
36	Neoplasms, Hormone-Dependent	14.8%
37	Neoplasms, Multiple Primary	14.8%
38	Paraneoplastic Syndromes	14.8%
39	Precancerous Conditions	14.8%
40	Neoplasms, Second Primary	14.8%
41	Neuroectodermal Tumors	14.7%
42	Histiocytic Disorders, Malignant	14.2%
43	Phyllodes Tumor	13.9%
44	Lipoma	13.9%
45	Myoma	13.9%
46	Angiolipoma	13.9%
47	Myelolipoma	13.9%
48	Smooth Muscle Tumor	13.9%
49	Desmoplastic Small Round Cell Tumor	13.9%
50	Sarcoma, Myeloid	13.3%
51	Neurofibrosarcoma	12.1%
52	Mastocytoma	12.1%
53	Mastocytosis, Systemic	11.9%
54	Neoplasms, Neuroepithelial	11.5%
55	Gliomatosis cerebri	11.5%
56	Rhabdomyosarcoma	11.1%
57	Adenoma	10.9%
58	Ameloblastoma	10.9%
59	Angiokeratoma	10.9%
60	Carcinoma	10.9%
61	Chordoma	10.9%
62	Hemangioma	10.9%
63	hemangiopericytoma	10.9%
64	Lymphangioma	10.9%
65	Mesenchymoma	10.9%
66	Nevus	10.9%
67	Teratoma	10.9%
68	Hepatoblastoma	10.9%
69	Mixed Tumor, Mullerian	10.9%
70	Germinoma	10.9%
71	Teratocarcinoma	10.9%
72	Angiofibroma	10.9%
73	Epithelioma	10.9%
74	Carcinoma 256, Walker	10.8%
75	Sarcoma, Experimental	10.7%
76	Lymphoma	10.6%
77	Cyst	9.9%
78	Neoplastic Processes	9.9%
79	Neoplastic Syndromes, Hereditary	9.9%
80	Pregnancy Complications, Neoplastic	9.9%
81	Neoplasms, Experimental	9.6%
82	Meningioma	9.2%
83	Trophoblastic Neoplasms	9.2%
84	Leukemia, Experimental	9.1%
85	melanoma	9%
86	Carcinoma, Ehrlich Tumor	8.8%
87	Dermoid Cyst	8.8%
88	Carcinoma, Lewis Lung	8.8%
89	Composite Lymphoma	8.8%
90	Leukemia, Plasma Cell	8.5%
91	Rhabdomyoma	8.3%
92	Sarcoma 180	8%
93	Lymphangioleiomyomatosis	8%
94	Basal cell carcinoma	8%
95	Carcinoma, Papillary	8%
96	Squamous cell carcinoma	8%
97	Craniopharyngioma	8%
98	Cystadenoma	8%
99	Mesothelioma	8%
100	Neuroectodermal Tumor, Melanotic	8%
101	Neuroendocrine Tumors	8%
102	Carcinoma, Basal Cell	8%
103	Endometrial Stromal Sarcoma	7.6%
104	Leukemia, Radiation-Induced	7.4%
105	Plasmacytoma	7.4%
106	Alveolar rhabdomyosarcoma	7.3%
107	Malignant histiocytosis	7.3%
108	Histiocytic sarcoma	7.3%
109	Neoplasms, Radiation-Induced	7.2%
110	Abdominal Neoplasms	7.1%
111	Erythroplasia	7.1%
112	Follicular cyst	7.1%
113	Head and Neck Neoplasms	7.1%
114	Mucocele	7.1%
115	Pilonidal Cyst	7.1%
116	Soft Tissue Neoplasms	7.1%
117	Thoracic Neoplasms	7.1%
118	Thyroglossal Cyst	7.1%
119	Synovial Cyst	7.1%
120	Aberrant Crypt Foci	7.1%
121	Adenoma, Acidophil	6.6%
122	Ganglioneuroma	6.6%
123	Glioma	6.6%
124	Malignant Glioma	6.6%
125	Thymoma	6.5%
126	Leukemia L1210	6.5%
127	Leukemia P388	6.5%
128	Acanthoma	6.5%
129	Cystadenocarcinoma	6.4%
130	Mucoepidermoid Carcinoma	6.4%
131	Multiple Endocrine Neoplasia	6.1%
132	Urticaria Pigmentosa	6%
133	Adenocarcinoma	6%
134	Carcinoma in Situ	6%
135	Carcinoma, Transitional Cell	6%
136	Dysgerminoma	6%
137	Hemangioendothelioma	6%
138	Neuroma	6%
139	Papilloma	6%
140	Pseudomyxoma Peritonei	6%
141	Seminoma	6%
142	Papillomatosis	6%
143	Adenomatosis, Pulmonary	6%
144	Adenomatous Polyps	6%
145	Carcinoma, Large Cell	6%
146	Carcinoma, Small Cell	6%
147	Melanoma, Experimental	5.9%
148	Paraneoplastic Encephalomyelitis	5.5%
149	Hodgkin Disease	5.5%
150	Lymphoma, Non-Hodgkin	5.5%
151	Mammary Neoplasms, Experimental	5.4%
152	Carcinoid Tumor	5.3%
153	Neurilemmoma	5.3%
154	Hutchinson's Melanotic Freckle	5.3%
155	Melanoma, Amelanotic	5.3%
156	Choriocarcinoma	5.3%
157	Carcinoma, Lobular	5.3%
158	Digestive System Neoplasms	5.1%
159	Endocrine Gland Neoplasms	5.1%
160	Eye Neoplasms	5.1%
161	Nervous System Neoplasms	5.1%
162	Bone neoplasms	4.8%
163	Leukoplakia	4.8%
164	Lymphocele	4.8%
165	Pancreatic Cyst	4.8%
166	Skin Neoplasms	4.8%
167	Hematologic Neoplasms	4.8%
168	Bowen's Disease	4.7%
169	Paraganglioma	4.7%
170	Barrett Esophagus	4.7%
171	Breast Cyst	4.7%
172	Actinic keratosis	4.7%
173	Mediastinal Cyst	4.7%
174	Neoplasm Invasiveness	4.7%
175	Neoplasm Metastasis	4.7%
176	Neoplasm Recurrence, Local	4.7%
177	Parovarian Cyst	4.7%
178	Pericardial Cyst	4.7%
179	Splenic Neoplasms	4.7%
180	Thymic Cyst	4.7%
181	Carcinogenesis	4.7%
182	Myxoid cyst	4.7%
183	Metastasis	4.7%
184	Medulloblastoma	4.7%
185	Primary amyloidosis	4.4%
186	Tuberous Sclerosis	4.3%
187	Nephroblastoma	4.3%
188	Lymphomatoid Granulomatosis	4.2%
189	Astrocytoma	4.1%
190	Ependymoma	4.1%
191	oligodendroglioma	4.1%
192	Ganglioglioma	4.1%
193	gliosarcoma	4.1%
194	Anaplastic astrocytoma	4.1%
195	Anaplastic Oligodendroglioma	4.1%
196	Leukemia, Myelomonocytic, Chronic	4%
197	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	4%
198	Retinoblastoma	3.9%
199	Retroperitoneal Neoplasms	3.6%
200	Adenoid Cystic Carcinoma	3.6%
201	Adenocarcinoma, Clear Cell	3.6%
202	Cholangiocarcinoma	3.6%
203	Cervical Intraepithelial Neoplasia	3.6%
204	Hemangioblastoma	3.6%
205	Lymphoma, Extranodal NK-T-Cell	3.6%
206	Malignant Carcinoid Syndrome	3.5%
207	Corpus Luteum Cyst	3.5%
208	Ovarian Cysts	3.5%
209	Mesoblastic Nephroma	3.4%
210	Hepatocellular Adenoma	3.3%
211	Waldenstrom Macroglobulinemia	3.2%
212	Multiple Myeloma	3.2%
213	Pheochromocytoma	3.1%
214	Multiple Endocrine Neoplasia Type 1	3.1%
215	Sturge-Weber Syndrome	3.1%
216	Basal Cell Nevus Syndrome	3.1%
217	Parathyroid Neoplasms	3%
218	Peritoneal Neoplasms	3%
219	Thyroid Neoplasm	3%
220	Thyroid carcinoma	3%
221	Hemangioma, Cavernous	3%
222	Liver Neoplasms, Experimental	3%
223	Leukemia, T-Cell	3%
224	Leukemia, B-Cell	3%
225	neurofibroma	3%
226	Lymphoma, Follicular	3%
227	T-Cell Lymphoma	3%
228	Mantle cell lymphoma	3%
229	Glioblastoma	2.9%
230	Neuroblastoma	2.9%
231	Glioblastoma Multiforme	2.9%
232	Choledochal Cyst	2.9%
233	Peutz-Jeghers Syndrome	2.8%
234	Hydatidiform Mole	2.8%
235	Prolactinoma	2.7%
236	Growth Hormone-Secreting Pituitary Adenoma	2.7%
237	Pancreatic Neoplasm	2.6%
238	Carcinoma, Pancreatic Ductal	2.5%
239	Mouth Neoplasms	2.5%
240	Central Nervous System Neoplasms	2.5%
241	Vascular Neoplasms	2.5%
242	Thymus Neoplasms	2.5%
243	Genital Neoplasms, Female	2.5%
244	Pancreatic Pseudocyst	2.5%
245	Lymphatic Metastasis	2.4%
246	Neoplasms, Unknown Primary	2.4%
247	Leukemic Infiltration	2.4%
248	Breast Neoplasms, Male	2.4%
249	Neoplasm Micrometastasis	2.4%
250	Triple Negative Breast Neoplasms	2.4%
251	Leukemia, Myeloid, Chronic-Phase	2.4%
252	Klatskin Tumor	2.4%
253	Tracheal Neoplasms	2.4%
254	Ganglioneuroblastoma	2.4%
255	granulosa cell tumor	2.3%
256	Carcinoma, Ovarian Epithelial	2.3%
257	Leukoplakia, Oral	2.3%
258	Paraneoplastic Cerebellar Degeneration	2.3%
259	Adenomatous Polyposis Coli	2.3%
260	Carcinoid Heart Disease	2.2%
261	Acoustic Neuroma	2.1%
262	Esophageal Neoplasms	1.9%
263	Adrenal Gland Neoplasms	1.9%
264	Gastrointestinal Neoplasms	1.9%
265	Genital Neoplasms, Male	1.9%
266	Liver neoplasms	1.9%
267	Uveal Neoplasms	1.9%
268	Limbic Encephalitis	1.9%
269	Optic Nerve Glioma	1.9%
270	Urologic Neoplasms	1.9%
271	Sebaceous Gland Neoplasms	1.8%
272	Spinal Neoplasms	1.8%
273	Bone Marrow Neoplasms	1.8%
274	Polycystic Ovary Syndrome	1.8%
275	Vipoma	1.8%
276	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	1.8%
277	Leukemia, Large Granular Lymphocytic	1.8%
278	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	1.8%
279	Lymphoma, T-Cell, Cutaneous	1.8%
280	Lymphoma, AIDS-Related	1.8%
281	Enteropathy-Associated T-Cell Lymphoma	1.8%
282	Primary Effusion Lymphoma	1.8%
283	insulinoma	1.7%
284	Nasopharyngeal carcinoma	1.7%
285	Lambert-Eaton Myasthenic Syndrome	1.7%
286	Testicular Neoplasms	1.7%
287	Thyroid Nodule	1.6%
288	Adrenocortical carcinoma	1.6%
289	Denys-Drash Syndrome	1.6%
290	Xeroderma Pigmentosum	1.6%
291	Opsoclonus-Myoclonus Syndrome	1.4%
292	Leydig Cell Tumor	1.4%
293	Gastrinoma	1.4%
294	Glucagonoma	1.4%
295	Renal Cell Carcinoma	1.4%
296	Papillary Renal Cell Carcinoma	1.4%
297	Meningeal Neoplasms	1.3%
298	Myelitis, Transverse	1.3%
299	Carcinoma, Endometrioid	1.2%
300	ovarian neoplasm	1.2%
301	Burkitt Lymphoma	1.2%
302	Mycosis Fungoides	1.2%
303	Lymphomatoid Papulosis	1.2%
304	Plasmablastic lymphoma	1.2%
305	Nose Neoplasms	1.1%
306	Ear Neoplasms	1.1%
307	Eyelid Neoplasms	1.1%
308	Lung Neoplasms	1.1%
309	Pleural Neoplasms	1.1%
310	Cell Transformation, Viral	1%
311	Brain Neoplasms	1%
312	Salivary Gland Neoplasms	1%
313	Spinal Cord Neoplasms	1%
314	Tongue Neoplasms	1%
315	Uterine Neoplasms	1%
316	Vaginal Neoplasms	1%
317	Vulvar Neoplasms	1%
318	Uterine Cancer	1%
319	Fallopian Tube Neoplasms	1%
320	Pituitary Adenoma	1%
321	Pituitary Neoplasms	1%
322	Palatal Neoplasms	0.9%
323	Zollinger-Ellison syndrome	0.9%
324	Pharyngeal Neoplasms	0.9%
325	Central Nervous System Cysts	0.8%
326	Bile Duct Neoplasms	0.8%
327	gallbladder neoplasm	0.8%
328	Intestinal Neoplasms	0.8%
329	Penile Neoplasms	0.8%
330	Prostatic Neoplasms	0.8%
331	Stomach Neoplasms	0.8%
332	Polycythemia Vera	0.8%
333	Sezary Syndrome	0.8%
334	Meningeal Carcinomatosis	0.8%
335	Laryngeal neoplasm	0.7%
336	Bladder Neoplasm	0.7%
337	Kidney Neoplasm	0.7%
338	Ureteral Neoplasms	0.7%
339	Urethral Neoplasms	0.7%
340	Bronchial Neoplasms	0.6%
341	Multiple Pulmonary Nodules	0.6%
342	Supratentorial Neoplasms	0.6%
343	Endometrial Neoplasms	0.6%
344	Hypopharyngeal Neoplasms	0.5%
345	Pleural Effusion, Malignant	0.5%
346	Hypopharyngeal Cancer	0.5%
347	Parotid Neoplasms	0.5%
348	Prostatic Neoplasms, Castration-Resistant	0.5%
349	Nelson Syndrome	0.5%
350	Cecal Neoplasms	0.4%
351	Duodenal Neoplasms	0.4%
352	Brain Stem Neoplasms	0.4%
353	Nasopharyngeal Neoplasms	0.4%
354	Colorectal Neoplasms	0.3%
355	Tonsillar Neoplasms	0.3%
356	Cerebellar Neoplasms	0.3%
357	Paranasal Sinus Neoplasms	0.3%
358	Choroid Plexus Papilloma	0.3%
359	Radicular Cyst	0.3%
360	Appendiceal Neoplasms	0.3%
361	Colonic Neoplasms	0.3%
362	Rectal Neoplasms	0.3%
363	Maxillary Sinus Neoplasms	0.2%
364	Anus Neoplasms	0.2%
365	Sigmoid Neoplasms	0.2%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262